| Khalid Hararah, MD | |
|
688 E Vine St Ste 16, Murray, UT 84107-5541 | |
| (801) 509-9138 | |
| (801) 797-0237 |
| Full Name | Khalid Hararah |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 688 E Vine St Ste 16, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053808501 | NPI | - | NPPES |
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
Kaiser Health News staff writer Jenny Gold, in collaboration with National Public Radio, goes to Springdale, Ark., the self-described "Chicken Capitol of the World," to report on an enclave of unlikely migrants - 6,000 people from the Marshall Islands - who are watching the health care debate with heightened interest.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
A new study into the way in which parasites interact with each other could help predict when infectious diseases are likely to break out.
› Verified 5 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Kaiser Health News staff writer Jenny Gold, in collaboration with National Public Radio, goes to Springdale, Ark., the self-described "Chicken Capitol of the World," to report on an enclave of unlikely migrants - 6,000 people from the Marshall Islands - who are watching the health care debate with heightened interest.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
A new study into the way in which parasites interact with each other could help predict when infectious diseases are likely to break out.
› Verified 5 days ago
| Entity Name | Bay Area Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225016561 PECOS PAC ID: 2163331000 Enrollment ID: O20040310000301 |
News Archive
Kaiser Health News staff writer Jenny Gold, in collaboration with National Public Radio, goes to Springdale, Ark., the self-described "Chicken Capitol of the World," to report on an enclave of unlikely migrants - 6,000 people from the Marshall Islands - who are watching the health care debate with heightened interest.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
A new study into the way in which parasites interact with each other could help predict when infectious diseases are likely to break out.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Khalid Hararah, MD 688 E Vine St Ste 16, Murray, UT 84107-5541 Ph: (801) 509-9138 | Khalid Hararah, MD 688 E Vine St Ste 16, Murray, UT 84107-5541 Ph: (801) 509-9138 |
News Archive
Kaiser Health News staff writer Jenny Gold, in collaboration with National Public Radio, goes to Springdale, Ark., the self-described "Chicken Capitol of the World," to report on an enclave of unlikely migrants - 6,000 people from the Marshall Islands - who are watching the health care debate with heightened interest.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
South Africa's new five-year HIV/AIDS plan is an "unprecedented cooperation" between the government and civil society organizations in the country, Glenda Gray, executive director of the Perinatal Health Research Unit at the University of the Witwatersrand, and David Harrison, CEO of loveLife, write in a Sunday Independent opinion piece.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
A new study into the way in which parasites interact with each other could help predict when infectious diseases are likely to break out.
› Verified 5 days ago
Lindsay Helm, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 E Myrtle Ave Ste 204, Murray, UT 84107 Phone: 801-369-8989 Fax: 801-704-9741 | |
Carl Edward Wyne, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5770 Fashion Blvd, Murray, UT 84107 Phone: 801-314-4544 | |
Dr. Marshall Nickel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 Fax: 801-746-3734 | |
Dr. Franz Medina Monroy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 181 E Medical Tower Dr, Murray, UT 84107 Phone: 801-314-4266 | |
Chase Sessions, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5171 S Cottonwood St Ste 305, Murray, UT 84107 Phone: 801-507-9310 | |
Lauren Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 181 E Medical Tower Dr, Murray, UT 84107 Phone: 801-314-4266 |